Some physicians have urged their colleagues and medical societies to move professional conferences out of states that ...

Gender-affirming hormone therapy may reduce the risk of prostate cancer in transgender women, but it may also increase the risk of biochemical recurrence and bone metastases in patients with prostate ...

Atezolizumab did not improve overall survival, progression-free survival, distant metastasis-free survival, or time to local failure.

The FDA has approved the Cologuard Plus test for colorectal cancer screening in adults age 45 years and older who are at average risk of colorectal cancer.

A 2023 survey showed that 24% of Americans who used online pharmacies had been exposed to harmful or substandard medications.

Female physicians remain underrepresented among residents entering high-compensation specialties, data suggest.

A machine learning survival model that selects patients for serious illness conversations can increase the rate of advance ...

Hypofractionated PMRT is safe and effective in breast cancer patients undergoing reconstruction and should be moved into ...

Prior results from the SHAPE trial showed that simple hysterectomy was noninferior to radical hysterectomy for oncologic ...

The FDA has approved Opdivo (nivolumab) as neoadjuvant and adjuvant treatment for adults with resectable NSCLC.

(HealthDay News) — Disparities in mortality between Black and White individuals in the United States decreased from 1999 to the 2010s but later increased, particularly during the first year of the ...